Notten Pascale, Strijkers Rob H W, Toonder Irwin, Ten Cate Hugo, Ten Cate-Hoek Arina J
Department of Vascular Surgery, Maastricht University Medical Centre, P.O. Box 5800, Maastricht, 6202 AZ the Netherlands.
CARIM, Cardiovascular Research Institute Maastricht, School for Cardiovascular Diseases, Maastricht University Medical Centre, P.O. Box 616, Maastricht, 6200 MD the Netherlands.
Thromb J. 2020 Sep 16;18:23. doi: 10.1186/s12959-020-00238-7. eCollection 2020.
The role of venous obstructions as a risk factor for recurrent venous thromboembolism has never been evaluated. This study aimed to determine whether there is a difference in prevalence of venous obstructions between patients with and without recurrent venous thromboembolism. Furthermore, its influence on the development of post-thrombotic syndrome and patient-reported quality of life was assessed.
This matched nested case-control study included 32 patients with recurrent venous thromboembolism (26 recurrent deep-vein thrombosis and 6 pulmonary embolism) from an existing prospective cohort of deep-vein thrombosis patients and compared them to 24 age and sex matched deep-vein thrombosis patients without recurrent venous thromboembolism. All participants received standard post-thrombotic management and underwent an additional extensive duplex ultrasonography. Post-thrombotic syndrome was assessed by the Villalta-scale and quality of life was measured using the SF36v2 and VEINES-QOL/Sym-questionnaires.
Venous obstruction was found in 6 patients (18.8%) with recurrent venous thromboembolism compared to 5 patients (20.8%) without recurrent venous thromboembolism (Odds ratio 0.88, 95%CI 0.23-3.30, = 1.000). After a median follow-up of 60.0 months (IQR 41.3-103.5) the mean Villalta-score was 5.55 ± 3.02 versus 5.26 ± 2.63 ( = 0.909) and post-thrombotic syndrome developed in 20 (62.5%) versus 14 (58.3%) patients, respectively (Odds ratio 1.19, 95%CI 0.40-3.51, = 0.752). If venous obstruction was present, it was mainly located in the common iliac vein ( = 7, 63.6%). In patients with an objectified venous obstruction the mean Villalta-score was 5.11 ± 2.80 versus 5.49 ± 2.87 in patients without venous obstruction ( = 0.639). Post-thrombotic syndrome developed in 6 (54.5%) versus 28 (62.2%) patients, respectively (Odds ratio 1.37, 95%CI 0.36-5.20, = 0.736). No significant differences were seen regarding patient-reported quality of life between either groups.
In this exploratory case-control study patients with recurrent venous thromboembolism did not have a higher prevalence of venous obstruction compared to patients without recurrent venous thromboembolism. The presence of recurrent venous thromboembolism or venous obstruction had no impact on the development of post-thrombotic syndrome or the patient-reported quality of life.
静脉阻塞作为复发性静脉血栓栓塞危险因素的作用从未被评估过。本研究旨在确定复发性静脉血栓栓塞患者与非复发性静脉血栓栓塞患者之间静脉阻塞的患病率是否存在差异。此外,还评估了其对血栓形成后综合征发展及患者报告的生活质量的影响。
这项匹配的巢式病例对照研究纳入了来自现有的深静脉血栓形成患者前瞻性队列中的32例复发性静脉血栓栓塞患者(26例复发性深静脉血栓形成和6例肺栓塞),并将他们与24例年龄和性别匹配的无复发性静脉血栓栓塞的深静脉血栓形成患者进行比较。所有参与者均接受标准的血栓形成后管理,并接受额外的广泛双功超声检查。通过Villalta量表评估血栓形成后综合征,并使用SF36v2和VEINES-QOL/Sym问卷测量生活质量。
6例(18.8%)复发性静脉血栓栓塞患者发现有静脉阻塞,而无复发性静脉血栓栓塞的患者中有5例(20.8%)发现有静脉阻塞(比值比0.88,95%置信区间0.23-3.30,P = 1.000)。中位随访60.0个月(四分位间距41.3-103.5)后,平均Villalta评分分别为5.55±3.02和5.26±2.63(P = 0.909),血栓形成后综合征分别在20例(62.5%)和14例(58.3%)患者中发生(比值比1.19,95%置信区间0.40-3.51,P = 0.752)。如果存在静脉阻塞,主要位于髂总静脉(n = 7,63.6%)。有明确静脉阻塞的患者平均Villalta评分为5.11±2.80,无静脉阻塞的患者为5.49±2.87(P = 0.639)。血栓形成后综合征分别在6例(54.5%)和28例(62.2%)患者中发生(比值比1.37,95%置信区间0.36-5.20,P = 0.736)。两组患者报告的生活质量方面未见显著差异。
在这项探索性病例对照研究中,与无复发性静脉血栓栓塞的患者相比,复发性静脉血栓栓塞患者的静脉阻塞患病率并不更高。复发性静脉血栓栓塞或静脉阻塞的存在对血栓形成后综合征的发展或患者报告的生活质量没有影响。